Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Oct 19;3(11):1473–1483. doi: 10.1158/1940-6207.CAPR-10-0123

Fig. 2.

Fig. 2

A, immunocytochemical analysis for pSTAT3 in DU145 cells following 3 or 24 hour treatment with DMSO (control) or DATS (20 or 40 µmol/L). B, immunocytochemical analysis for pSTAT3 in LNCaP cells following 3 hour treatment with DMSO (control) or DATS (20 or 40 µmol/L) in the absence or presence of 25 ng/mL IL-6. C, immunocytochemical analysis for pSTAT3 in LNCaP cells following 24 hour treatment with DMSO (control) or DATS (20 or 40 µmol/L) in the absence or presence of 25 ng/mL IL-6. Staining for pSTAT3 and nuclear DNA are indicated by red and green fluorescence, respectively (×100 objective magnification). Each experiment was repeated twice, and representative data from one such experiment are shown.